Background: Terminal digit preference in blood pressure (BP) measurement has been reported in both clinical and research settings. This article examines the prevalence of terminal digit preference (TDP) in primary care practices and the effect that a practice's level of TDP influences patients' BP measurements and management.
W
ith respect to blood pressure (BP) measurement, terminal digit preference (TDP) describes an observer's tendency to record the measurement using certain digits (eg, 0) in the unit's position more frequently than other digits (eg, 7). Terminal digit preference has been reported to occur in a variety of clinical [1] [2] [3] [4] [5] and research 6, 7 settings. The BP measurements are significantly more likely to end in zero than any other digit, and even numbers are generally preferred over odd. The number five is the most frequently reported odd terminal digit. 1 Although the bias introduced by TDP may clearly affect an individual patient's BP measurement on a particular day, the potential also exists for this bias to affect the patient's treatment and management. Because guidelines for diagnosing and managing hypertension (HTN) and pre-HTN involve the use of threshold values (eg, 140 mm Hg for systolic BP, 90 mm Hg for diastolic BP), 8 TDP could influence whether a patient is given a diagnosis of HTN or pre-HTN, or whether the patient is started on BP-lowering therapy, including antihypertensive medication. One study 9 found elevated mortality rates among women (but not men) with diastolic BPs ranging from 88 to 89 mm Hg compared to women whose diastolic PBs ranged from 90 to 99 mm Hg, suggesting that "certain observers, mainly nurses, recorded a lower reading than they first observed or repeated the measurement until they had a value that was more acceptable, with adverse consequences for some female patients."
This article examines the prevalence of TDP in 85 primary care practices and the effect that a primary care practice's level of TDP influences patients' BP measurements and patterns of prescribing selected medications.
Methods

Study Population
The study population includes 327,583 adult patients from 85 physician practices throughout the United States. The practices are part of Practice Partner Research Network (PPRNet), a network of ambulatory care (mostly primary care) clinicians throughout the United States who use a common electronic medical record (Practice Partner, Physician Micro Systems, Inc., Seattle, WA). Data from outpatient encounters (eg, demographics, diagnoses, medications, laboratory results, vital signs) are remitted quarterly to PPRNet staff at the Medical University of South Carolina, where the data are prepared for analysis and summarized in practice performance reports. The PPRNet patient data do not contain identifiers than can be used to identify specific individuals. Consent from the practice is implied if they send their data for use by PPRNet. The Medical University of South Carolina Institutional Review Board has approved this approach.
Because the electronic medical record software allows for free-text entry for many of the data fields, PPRNet staff clinicians routinely "bridge" the entries for selected diagnoses and medications. Unique diagnoses and medications are reviewed by PPRNet staff, and new variables are created that contain the bridged information. For example, free-text provider diagnosis entries of "essential HTN," "HTN," or variations/misspellings such as "hypetrension" are all bridged to "Hypertension" by a physician, whereas prescriptions for "captopril," "enalapril," or their variations/misspellings are bridged to the angiotensin-converting enzyme (ACE) inhibitor class of antihypertensive medications by a Pharm.D. For this study, the following diagnoses were available through this bridging process to be used as covariates: HTN, diabetes, coronary heart disease, hyperlipidemia, heart failure, atrial fibrillation, and other atherosclerotic disease. Antihypertensive classes bridged for this analysis included: angiotensin II inhibitors, ACE inhibitors, ␤-blockers, calcium channel blockers, central-and peripheral-acting antiadrenergic agents, loop diuretics, potassium-sparing diuretics, spironolactone, thiazide diuretics, and vasodilators.
The study is a cross-sectional analysis of active adult patients in the 85 practices that supplied sufficient data to PPRNet through September 30, 2004. The patient-level analysis dataset included the most recent systolic and diastolic BP measurements along with demographic data (age, gender), indicator variables for the previously mentioned diagnoses, an indicator for whether or not he/she had an active (ie, within 1 year) prescription for an antihypertensive medication, and a practice identifier. A patient was considered to have an "up-to-date" BP measurement if it had been obtained within the past 2 years, unless he/she had a diagnosis of HTN or diabetes, in which case the measurement needed to have been obtained within the past 6 months, an approach consistent with the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-VII) guidelines. 8 Informal discussion with practice staff indicates that BP measurement techniques, including, for example, the use of automated devices, the type and training of clinicians doing the measurement, and the number of BPs measured during a patient's visit, vary significantly within and among practices.
The level of TDP was assessed for each practice by calculating the percentage of its patients' most recent systolic BPs and diastolic BPs that ended in zero, and these two percentages were averaged to obtain an overall level of TDP. Frequencies of systolic and diastolic BP terminal digits were summarized, stratified by whether practices' TDP levels were Ͻ15% or Ն15%. This cutoff was chosen to highlight differences in digit preference between practices that are likely to routinely use electronic BP recording devices and practices that are not. The effect of practices' level of TDP on patients' systolic and diastolic BP was assessed using a mixed linear regression model approach. 10 This technique serves two purposes. By incorporating random practice effects, the models account for correlation of BPs for patients within the same practice (ie, the hierarchical nature of patients being clustered within practices), and they also allow for the assumption that the physician practices are representative of the larger population of practices that use electronic medical records. Two models were constructed, in which the primary dependent variables of interest were the patient's BPs (systolic and diastolic BP), and the primary independent variable was the practice's TDP level. Covariates included patient age, gender, and whether or not the patient had a diagnosis of one of the following conditions: HTN, diabetes, coronary heart disease, hyperlipidemia, heart failure, atrial fibrillation, or other atherosclerotic disease.
Another approach was taken to determine whether practices' TDP levels were correlated with a different type of bias 6, an increased/decreased likelihood of labeling patients with borderline BPs (ie, between 137 and 143 mm Hg) as being normotensive (Ͻ140 mm Hg) rather than hypertensive (Ն140 mm Hg). Patients with systolic BPs between 137 and 143 mm Hg were selected, and the proportion of these patients whose systolic BPs were between 140 and 143 mm Hg was calculated. The association between this proportion and practice's TDP levels was assessed using a Pearson correlation.
A series of generalized linear mixed models were constructed to examine the possible influence of practice's TDP levels on a number of binary measures, including whether a patient's BP measurement has been monitored within an appropriate time frame (ie, within the past 6 months for patients with diabetes or HTN, within the past 2 years otherwise), whether a patient's BP is below recommended targets (ie, Ͻ130/80 mm Hg for patients with diabetes, Ͻ140/90 mm Hg otherwise), whether or not a patient has a current diagnosis of HTN, and whether or not a patient has an active prescription (ie, one written in the past year) for any antihypertensive medication. Proc GLIMMIX (SAS V9.1, Cary, N.C.) was used for these analyses. The GLIMMIX procedure allows for a dependent binary variable as well as the random effect of physician practice as an independent variable. Again the primary independent variable of interest was the practice TDP level, and patient-level covariates were identical to those described for the BP models. Because of the earlier finding that TDP may differentially impact men and women, significant findings also subjected to gender-stratified analyses.
Results
In these 85 practices, the most recent BP was recorded for 327,583 unique patients. Across all practices, 87.2% of patients had up-to-date BP measurements, and 74.0% of patients with BP measurements were normotensive (ie, Ͻ140/90 mm Hg). A total of 24.1% of patients had a diagnosis of HTN, and 27.0% of all patients (73.4% of hypertensive patients) had an active prescription for an antihypertensive agent. The distribution of terminal digits appearing in these BP measurements is summarized in Table 1 , with separate distributions for practices with TDP levels Ͻ15% and Ն15%. The preference was similar for systolic and diastolic BP, with zero being recorded most frequently (44.6% of systolic BPs and 47.5% of diastolic BPs), followed by two, eight, four, six, five, nine, seven, three, and one. Non-zero even digits were preferred significantly more often (51.2% of systolic BPs, 48.3% of diastolic BPs) than odd digits (4.2% of systolic BPs, 4.2% of diastolic BPs). Table 2 lists the distribution of TDP levels (range: 11.33%-81.09%) across the 85 practices.
The mean level of systolic TDP for the practices was 44.6%, ranging from 9.5% to 80.3%, whereas the mean level of diastolic TDP was 47.4%, ranging from 10.9% to 81.9%. The overall measure of TDP (ie, the average of systolic BP TDP and diastolic BP TDP used in the hierarchical models) had a mean of 46.0% and ranged from 11.3% to 81.1%. There were five practices identified with a level of TDP less than 15%, and it was confirmed that these practices used one or more electronic BP recording devices. Practices' TDP levels were strongly and positively correlated with their proportions of systolic BPs between 137 and 143 mm Hg, which were between 140 and 143 mm Hg (r ϭ 0.72, P Ͻ .0001). In other words, practices with high TDP levels were more likely to rate this select group of patients as hypertensive (Ͼ140 mm Hg). When patients with HTN alone were compared to patients with HTN plus at least one other cardiovascular comorbidity (diabetes mellitus, coronary heart disease, hyperlipidemia, heart failure, atrial fibrillation, or other Results of the mixed models indicated that after adjusting for the patient-level covariates, patients' systolic BP measurements overall were significantly (␤ ϭ Ϫ0.74, P Ͻ .01) associated with practices' TDP levels; however, their diastolic BP measurements were not (P ϭ .294). On average, a 10% absolute increase in a practice's TDP level corresponded to a 0.74 mm Hg lower systolic BP. In other words, patients in a practice with a TDP level of 50% (ie, BP measurements in this practice end in zero 50% of the time) have, on average, systolic BPs that were 2.96 mm Hg lower than patients in practice with a TDP level of 10% (ie, it would be expected in a practice with electronic BP recording devices). These findings remained relatively unchanged (systolic BP: P ϭ .017; diastolic BP: P ϭ .494) when practices with low TDP levels (ie, Ͻ15%) were excluded from the analyses, and results were relatively similar for men (␤ ϭ Ϫ0.68, P ϭ .001) and women (␤ ϭ Ϫ0.76, P ϭ .001).
Results of the generalized linear mixed models indicate that practices' TDP levels were not associated with the frequency of BP monitoring (ie, within the past 6 months for patients with diabetes or HTN, within the past 2 years otherwise) (P ϭ .33), whether or not a patient's BPs was under the recommended target (P ϭ .37), or whether or not a patient had a current diagnosis of HTN (P ϭ .41). The TDP level for patients with HTN was 45.3%, compared to 46.2% for patients without HTN, a difference that was also not statistically significant. However, across the entire patient population, each 10 percentage point increase in a practice's TDP level was associated with an 8% decrease (odds ratio [OR] ϭ 0.92, 95% confidence interval [CI]: 0.85, 0.99, P ϭ .036) in the likelihood that patients would have a current prescription for an antihypertensive medication. Interestingly, this effect diminishes considerably (OR ϭ 0.98, 95% CI: 0.91, 1.05, P ϭ .58) when the effect of TDP levels on antihypertensive medication use is examined in patients with HTN. When the model examining the effect of TDP on the use of antihypertensive medications was stratified by gender, it was noted that the association was noticeable among women (OR ϭ 0.91, 95% CI 0.84, 0.99, P ϭ .023), but not men (OR ϭ 0.95, 95% CI 0.88, 1.03, P ϭ .21).
Discussion
This study confirms the fact that TDP occurs frequently in the primary care setting. On average, 44.6% and 47.5% of patients' systolic and diastolic BPs, respectively, ended in zero, results that were much higher than the 10% that would be expected if electronic BP recording devices were used 100% of the time. The study also quantifies the level to which a practice's TDP level is associated with patients' systolic and diastolic BP measurements, with higher TDP levels being associated with slightly (but significantly) lower systolic BP measurements, on average. Although TDP does not appear to be associated with the frequency of patients' BP monitoring, the likelihood that their BP is under a recommended target, or the diagnosis of HTN, the study does suggest that a practice's TDP level is associated with the odds of patients, especially women, having current prescriptions for antihypertensive medications, indicating that treatment for HTN may be significantly influenced by the manner in which patients' BP measurements are recorded. An alternative explanation could be that higher TDP levels are associated with greater use of nonpharmacologic therapy. However, this is not verifiable within the current data, given that such therapies are not reliably recorded in the PPRNet database. It appears that higher TDP levels may have a downward bias on BP measurements (especially systolic BP), which results in fewer patients receiving antihypertensive prescriptions than do in practices with low TDP levels. Further investigation of the modeling results suggests that an average practice of 1000 patients with a 50% TDP level has approximately 68 patients who do not have an active prescription for an antihypertensive but who would have had there been no TDP in that practice.
The high prevalence of TDP in this group of primary care practices should not be surprising. One study of 85,000 BP measurements in patients with ischemic heart disease in England found that zero preference accounted for 64% of systolic and 59% of diastolic BP measurements. 1 Zero was the terminal systolic BP digit in 40% and 31% of readings taken by nursing staff and physicians, respectively, in one specialty HTN faculty practice, 2 and in 57.8% of physician readings in another HTN clinic. 3 Problems with zero preference in BP readings have been reported in a variety of other clinical 4, 5 and research settings. 6, 7 A study involving an industrial screening program had similar results, where 78.5% of systolic and 74.2% of diastolic BP measurements on 7615 white miners were digit-preferenced, 11 and zero preference occurred in 78% of systolic BP measurements in another study of 28,841 pregnant women. 12 To some extent, the implications of TDP have been discussed in earlier reports. Hessel 11 showed that the associations between BP and both body mass index (BMI) and age showed greater error variance when digit-preferenced BP readings were used compared to unbiased readings. Another study showed that the classification of HTN among patients was significantly influenced by a strong tendency to read BP measurements to the nearest 10; changing the HTN definition from systolic BP Ն140 mm Hg to systolic BP Ͼ140 mm Hg resulted in a substantially decreased prevalence of HTN (from 25.9% to 13.3%).
Previous reports have outlined ways to reduce TDP in practice. Wingfield et al 6 discussed such methods in the Syst-Eur trial, a trial aimed at testing treatment of older patients with isolated systolic HTN. One of the stated objectives was to identify and reduce TDP using provider feedback, which consisted primarily of chart reminders. These methods resulted in a decrease in the use of zero as the terminal digit, from 42.4% to 22.0% during the span of 6 years. Automated devices have been recommended for some time as a means of reducing this type of bias, 5 and more recently Wingfield et al 6 mention that such devices have been shown to reduce TDP in other studies such as the Anglo-Scandinavian Cardiac Outcomes Trial (AS-COT) 13 and Hypertension Optimal Treatment (HOT) 14 trials. Proper training of healthcare providers who perform BP measurement has also been advocated as a means of reducing error. 7, 15 In fact, after two readers underwent training for measuring BP in the 1999 -2000 National Health and Nutrition Examination Survey (NHANES), their preferences for zero among systolic BPs were 19% and 23%, whereas their preferences for zero among diastolic BPs were 20% and 26%, respectively.
For a variety of reasons, a controversy exists about whether auscultatory devices (especially those containing mercury) used to measure BP should be phased out in favor of oscillometric devices. 16 Some researchers have noted considerable problems associated with a lack of mastery of the auscultatory technique by medical and nursing staff and potential adverse environmental consequences associated with mercury use, resulting in the call for total abandonment of the mercury sphygmomanometer. 17 Although some have reported higher BPs when the measurements were obtained by physicians and nurses when compared to automated devices, 18 other researchers have found no differences between readings by physicians using the auscultatory technique versus automated devices. 19 The National Institutes of Health has launched their "Mad as a Hatter Campaign" to "eliminate all unnecessary uses of mercury in the NIH facilities," and many major healthcare and research facilities are now mercuryfree. 20 On the other side of the argument, the Council for High Blood Pressure Research of the American Heart Association recommended in 2001 that mercury sphygmomanometers not be abandoned, over concerns of significant adverse health consequences, should less accurate devices become more widely used. 21 Our study does have some limitations. Because it is cross-sectional, it is not possible to determine whether high TDP levels are causally related to lower systolic BPs or decreased use of anti-HTN agents. There was also limited information on the specific measurement techniques, training of clinicians, or device calibration within the practices. Determining the extent to which TDP is associated with such factors was beyond the scope of this study.
The results of this study suggest that TDP has clinically and statistically significant implications assessment and treatment of high BP. Future efforts should focus on means to reduce TDP in clinical and settings, for example, using well-validated and calibrated automated noninvasive BP monitors. 22 
